George Nick Papaliodis, M.D.
This page shows the publications co-authored by George Papaliodis and James Chodosh.
Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II. Am J Ophthalmol. 2022 Jul 16; 243:42-54.
Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy. Semin Ophthalmol. 2016; 31(1-2):178-87.
Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm. 2010 Aug; 18(4):275-80.
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities. Cornea. 2018 Feb; 37(2):248-251.
Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update. Ocul Immunol Inflamm. 2017 Jun; 25(3):413-417.
Cost effectiveness of the type II Boston keratoprosthesis. Eye (Lond). 2011 Mar; 25(3):342-9.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.